Hyperimmune globulin

Hyperimmune globulin

Hyperimmune globulin, also known as hyperimmune immunoglobulin, is a type of immunoglobulin that is specifically formulated to provide targeted immunity against a particular pathogen or toxin. It is derived from the plasma of individuals who have been exposed to or vaccinated against the specific antigen of interest. Hyperimmune globulin is used for both prevention and treatment of certain infectious diseases.

Production

Hyperimmune globulin is produced through a process called plasmapheresis. Plasma donors who have high levels of antibodies against a specific pathogen are selected, and their plasma is collected and processed to isolate the hyperimmune globulin. The resulting product is then purified and standardized to ensure consistency in potency and efficacy.

Uses

Hyperimmune globulin is used in the prevention and treatment of various infectious diseases, including rabies, hepatitis B, and cytomegalovirus infections. It is also used in the management of certain autoimmune disorders, such as idiopathic thrombocytopenic purpura and Kawasaki disease.

In addition, hyperimmune globulin may be administered to individuals who have been exposed to a specific pathogen to provide immediate immunity and prevent the development of disease. This is particularly important in outbreak situations or in individuals who are at high risk of complications from infection.

Administration

Hyperimmune globulin is typically administered intravenously, although some formulations may be given subcutaneously. The dosage and frequency of administration depend on the specific indication and the patient's clinical condition. It is important to follow the recommendations of healthcare providers and adhere to the prescribed treatment regimen to ensure optimal efficacy.

Side Effects

Like other immunoglobulin products, hyperimmune globulin may cause side effects such as headache, fever, and allergic reactions. These side effects are usually mild and transient, but in rare cases, more serious adverse events may occur. Patients should be monitored closely during and after administration of hyperimmune globulin to detect and manage any potential complications.

‎

---

Translate: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, தமிழ், తెలుగు, Urdu, ಕನ್ನಡ, Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, বাংলা
European español, Deutsch, français, Greek, português do Brasil, polski, română, русский, Nederlands, norsk, svenska, suomi, Italian
Middle Eastern & African عربى, Turkish, Persian, Hebrew, Afrikaans, isiZulu, Kiswahili,
Other Bulgarian, Hungarian, Czech, Swedish, മലയാളം, मराठी, ਪੰਜਾਬੀ, ગુજરાતી, Portuguese, Ukrainian